CLINICAL EFFICACY AND SAFETY OF TOLTERODINE COMPARED TO PLACEBO IN DETRUSOR OVERACTIVITY
- 1 May 1999
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 162 (5) , 1551-1555
- https://doi.org/10.1097/00005392-199905000-00036
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladderBritish Journal of Urology, 1998
- Efficacy and safety of tolterodine in patients with detrusor instability: a dose‐ranging studyBritish Journal of Urology, 1998
- Tolterodine-a new bladder selective muscarinic receptor antagonist: Preclinical pharmacological and clinical dataLife Sciences, 1997
- OxybutyninDrugs & Aging, 1995
- Randomized, Double-Blind, Multicenter Trial on Treatment of Frequency, Urgency and Incontinence Related to Detrusor Hyperactivity: Oxybutynin versus Propantheline versus PlaceboJournal of Urology, 1991
- Oxybutynin Hydrochloride (3 mg) in the Treatment of Women with Idiopathic Detrusor InstabilityBritish Journal of Urology, 1990
- Pharmacokinetics and Clinical Effects of Oxybutynin in Geriatric PatientsJournal of Urology, 1988